HIV/AIDS Therapy

High-dose interferon effective in patients coinfected with hepatitis C

Published in AIDS Weekly, January 20th, 2003

by Michael Greer, senior medical writer - Interferon (IFN) treatment may be effective for both HIV and hepatitis C virus (HCV) infection, according to a researcher in Japan.

Working at Ogikubo Hospital in Tokyo, Hideji Hanabusa assessed the efficacy of high-dose IFN therapy in hemophiliacs coinfected with HIV and HCV.

IFN-treated patients achieved significant reductions in levels of both viral pathogens, Hanabusa reported.

A group of 30 patients - 15 coinfected with HIV and HCV and 15 age-matched patients infected with HCV alone - received high-dose IFN-alpha2a therapy for 24 weeks. HIV viral loads dropped from roughly 7410...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-01-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry